Mitoferrin Inhibitors

Chemical inhibitors of Mitoferrin can disrupt its essential role in mitochondrial iron transport, which is crucial for processes such as heme and iron-sulfur cluster synthesis. Deferasirox and Deferoxamine are iron chelators; their primary mechanism of inhibition resides in their ability to sequester iron, thereby reducing its cellular availability. By binding to iron, these chemicals diminish the substrate that Mitoferrin typically transports into the mitochondria, effectively inhibiting its function. Ciclopirox, another iron chelator, operates similarly by decreasing the intracellular iron pool, while 2,2'-Bipyridyl and Pyridoxal isonicotinoyl hydrazone (PIH) both bind iron, thereby restricting the essential substrate from Mitoferrin's transport activity. These actions collectively contribute to a reduction in the intracellular iron that is available for Mitoferrin to transport into the mitochondria, thus inhibiting its function.

In parallel, other chemicals such as Mimosine and Bathophenanthroline act as iron chelators, which can directly inhibit Mitoferrin by sequestering iron. This sequestration limits the availability of iron for Mitoferrin to transport, resulting in functional inhibition. Tetracycline, which binds to metal ions, can indirectly inhibit Mitoferrin by altering metal ion homeostasis, potentially affecting the transport of iron into the mitochondria. O-Phenanthroline, through its iron-chelating ability, can reduce the amount of free iron necessary for Mitoferrin's transport function. Stains-all is known to bind various metal ions, which could lead to an inhibition of Mitoferrin by modifying the balance of metal ions, including iron. Lastly, Zileuton, which is primarily known for its action on 5-lipoxygenase, can also sequester iron ions, further contributing to the inhibition of Mitoferrin by diminishing the bioavailable iron required for mitochondrial iron transport.